Sana Biotechnology, Inc.
SANA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $33 | $40 | $39 | $34 |
| G&A Expenses | $10 | $10 | $11 | $17 |
| SG&A Expenses | $10 | $10 | $11 | $17 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $45 | $0 | $0 |
| Operating Expenses | $44 | $95 | $51 | $51 |
| Operating Income | -$44 | -$95 | -$51 | -$51 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $1 | $1 | $2 |
| Pre-Tax Income | -$42 | -$94 | -$49 | -$49 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$42 | -$94 | -$49 | -$49 |
| % Margin | – | – | – | – |
| EPS | -0.16 | -0.39 | -0.21 | -0.21 |
| % Growth | 59% | -85.7% | 0% | – |
| EPS Diluted | -0.16 | -0.39 | -0.21 | -0.21 |
| Weighted Avg Shares Out | 260 | 238 | 238 | 236 |
| Weighted Avg Shares Out Dil | 260 | 238 | 238 | 236 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $3 | $4 | $6 |
| EBITDA | -$39 | -$48 | -$47 | -$45 |
| % Margin | – | – | – | – |